Diabetic retinopathy : Rapid improvement in blood glucose control, as seen with some GLP-1 receptor agonists, has been associated with early worsening of diabetic retinopathy in people with pre-existing retinal disease
Most available data comes from observational studies, post-hoc analyses, or research focused on metabolic outcomes in patients who happen to have coexisting inflammatory conditions
To keep patients safe and outcomes strong, consider the following clinical best practices: Start low, go slow on dosing Monitor for GI symptoms, especially early on Revisit mental health and vision concerns routinely Avoid use in patients with thyroid cancer history Stay alert for signs of pancreatitis or gallbladder issues Smart oversight matters
Let us help you become the healthiest version of yourself
Therefore, 0.6 mM PA concentration was selected for subsequent experiments
The medication also improves insulin sensitivity and may preserve lean muscle mass during weight loss, a critical advantage over calorie restriction alone